Med Chem Res (2011) 20:1438–1444
1443
5-(5-Chloro-3-methyl-1-phenylpyrazol-4-yl)methylene-2,
2-dimethyl-1,3-dioxane-4,6-dione (3f)
and organic phases. The catalyst present in the aqueous
layer was used for the subsequent cycle.
m.p: 240–242°C. %CHN found. (Calcd) for C17H15N2
O4Cl: C, 58.94 (58.90); H, 4.35 (4.32); N, 8.03 (8.07). IR
(KBr, cm-1): 1725 (C=O). 1H NMR (CDCl3, 300 MHz): d
1.59 (s, 6H, 2 CH3), 2.52 (s, 3H, CH3), 7.00–7.73 (m, 6H,
Ar–H ? CH=C). FAB-MS: (%) m/z 347 (M?, 90).
2-(5-Chloro-3-methyl-1-phenylpyrazol-4-yl)methylene-1,
3-indanedione (3a)
m.p: 199–202°C. %CHN found. (Calcd) for C20H13
N2O2Cl: C, 68.96 (68.89); H, 3.77 (3.72); N, 8.08 (8.03).
IR (KBr, cm-1): 1689 (C=O). 1H NMR (CDCl3,
400 MHz): d 2.40 (s, 3H, CH3), 7.45–8.04 (m, 9H, Ar–H),
7.80 (s, 1H, –CH=C). FAB-MS: (%) m/z 349 (M?, 100).
4-(5-Chloro-3-methyl-1-phenylpyrazol-4-yl)methylene-3-
methyl-1-phenylpyrazol-5-one (3h)
m.p: 186–188°C. %CHN found. (Calcd) for C21H17N4OCl:
C, 66.92 (66.96); H, 4.49 (4.51); N, 14.83 (14.86). IR (KBr,
5-(5-Chloro-3-methyl-1-phenylpyrazol-4-yl)methylene-
2,4,6-pyrimidinetrione (3b)
cm-1): 1730 (C=O). H NMR (CDCl3, 400 MHz): d 2.41
(s, 6H, 2CH3), 4.93 (s, 1H, –CH=C), 7.23–7.76 (m, 10H,
1
m.p:[300°C. %CHN found. (Calcd) for C15H11N4O3Cl: C,
54.56 (54.49); H, 3.36 (3.32); N, 16.87 (16.94). IR (KBr,
cm-1): 1679 (C=O), 3195 (NH). 1H NMR (DMSO-d6,
300 MHz): d 2.29 (s, 3H, CH3), 7.31–7.82 (m, 5H, Ar–H),
8.12 (s, 1H, –CH=C), 11.05 (s, 1H, NH), 11.36 (s, 1H,
NH). ESI-MS: m/z 330.20 (M?).
Ar–H). FAB-MS: (%) m/z 376 (M?, 100).
Biological activity
Antibacterial studies
All the synthesized compounds were dissolved to prepare a
stock solution of 1 mg/ml using DMSO. The antibacterial
activity of test compounds and standard chloramphenicol
was done by filter paper disk method (Bauer et al., 1966).
Media with DMSO was set up as control. All cultures were
routinely maintained on NA (nutrient agar) and incubated
at 37°C for overnight. The culture was centrifuged at
1000 rpm, and pellets were resuspended and diluted in
sterile NSS to obtain viable count 105 cfu/ml. Approxi-
mately, 0.1 ml of diluted bacterial culture suspension was
spread with the help of spreader on NA plates uniformly.
Sterile 8-mm disks (Hi-media Pvt Ltd) were impregnated
with the test compounds. Antibiotic disk, chloramphenicol
(30 lg/disc Hi-Media), was used as control. The disk was
placed on to the plate. Each plate had one control disk
impregnated with the solvent. The plates were then incu-
bated for 24 h at 37°C, and the resulting zones of inhibition
(in mm) were measured.
5-(5-Chloro-3-methyl-1-phenylpyrazol-4-yl)methylene-1,
3-dimethyl-2,4,6-pyrimidinetrione (3c)
m.p: 208–210°C. %CHN found. (Calcd) for C17H15N4O3
Cl: C, 56.99 (56.93); H, 4.16 (4.18); N, 15.56 (15.61). IR
(KBr, cm-1): 1664 (C=O). 1H NMR (CDCl3, 400 MHz): d
2.43 (s, 3H, CH3), 3.42 (s, 3H, N–CH3), 3.45 (s, 3H, N–
CH3), 7.32–7.84 (m, 5H, Ar–H), 8.48 (s, 1H, –CH=C).
FAB- MS: (%) m/z 358 (M?, 90).
5-(5-Chloro-3-methyl-1-phenylpyrazol-4-yl)methylene-2-
mercapto-4,6-pyrimidinedione (3d)
m.p: [300°C. %CHN found. (Calcd) for C15H11N4O2SCl:
C, 51.99 (51.97); H, 3.13 (3.17); N, 16.07 (16.15). IR (KBr,
1
cm-1): 1007 (C=S), 1674 (C=O), 3124 (NH). H NMR
(DMSO-d6, 300 MHz): d 2.32 (s, 3H, CH3), 7.34–7.84 (m,
5H, Ar–H), 8.22 (s, 1H, –CH=C), 11.12 (s, 1H, NH), 11.43
(s, 1H, NH). ESI-MS: m/z 346.15(M?).
Antifungal studies
The synthesized compounds were dissolved in DMSO.
Media with DMSO was set up as control. All cultures were
routinely maintained on SDA and incubated at 28°C. Spore
formation of filamentous fungi was prepared from 7-day-
old culture in sterile normal solution (8% NaCl) and
approximately diluted to obtain 105 cfu/ml. The inoculum
of non-sporing fungi, Candida albicans were performed by
growing the culture in SD broth at 37°C for overnight. The
culture was centrifuged at 1000 rpm, and pellets were
resuspended and diluted in sterile NSS to obtain viable
2-(5-Chloro-3-methyl-1-phenylpyrazol-4-yl)methylene-1,
4-benzothiazine-3-one (3e)
m.p: 114–116°C (dec). %CHN found. (Calcd) for
C19H14N3OSCl: C, 62.08 (62.06); H, 3.83 (3.80); N, 11.39
(11.42). IR (KBr, cm-1): 1653 (C=O), 3185 (NH). 1H NMR
(CDCl3, 400 MHz): d 2.33 (s, 3H, CH3) 7.12–8.02 (m, 10H,
Ar–H ? CH=C), 9.61 (br s, 1H, NH). FAB-MS: (%) m/z 368
(M?, 70).
123